Stockreport

NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy [Yahoo! Finance]

Neuropace, Inc.  (NPCE) 
PDF The RNS System PAS evaluates safety and effectiveness of the RNS System in the adult focal population – the largest patient segment of drug resistant epilepsy MOUNTAI [Read more]